The right relationship
with the right KOL
changes everything.
In Italian healthcare, clinical adoption of a new device rarely follows a purchase decision. It follows a relationship. CCi brings 20+ years of direct KOL relationships — built procedure by procedure, meeting by meeting — and puts them to work for your device.
This solution is right for you if:
You have a device that requires clinical adoption before it can drive procurement decisions
You don't know who the right KOLs are for your device category in Italy
Your reps are struggling to get access to senior clinicians and department heads
You need to build scientific and clinical credibility before approaching procurement
You are entering a competitive category where incumbent relationships are the main barrier
20 years of relationships. Built the only way they can be — one at a time.
A KOL relationship in Italian healthcare is not made with an email or a congress badge. It is built through clinical credibility, through being present at the right moments, through years of honest exchange between a clinician and a commercial partner who genuinely understands the product.
CCi's network was built exactly this way — over 20 years, across Italy's leading IRCCS, university hospitals and regional centres of excellence. These are not contacts in a CRM. They are relationships that produce results: first procedures, departmental adoption, tender support, published studies.
"These are not contacts in a database. They are relationships built in operating theatres, in department meetings, in corridors after difficult procedures. That is what moves a medical device in Italy."
When CCi engages a KOL on behalf of a client, that KOL already knows and trusts the person making the introduction. That changes everything about the speed and quality of the conversation.
Clinical specialties
Institution types
Geographic coverage
Stakeholder profiles
From KOL identification to clinical adoption — managed end to end.
CCi's Key Account Management service covers every stage of the clinical relationship cycle — from identifying the right KOLs for your device category to managing the ongoing relationships that drive adoption, reorder and scientific endorsement.
KOL mapping & identification
A structured mapping of the most influential clinicians in your device category — by region, by institution type, by clinical volume. Ranked by influence, accessibility and strategic value for your specific product.
Relationship introduction & warm outreach
Where CCi has an existing relationship, we make the introduction directly — warm, credible, contextualised. Where new relationships need to be built, we design the right approach from the first contact.
Clinical engagement programme
A structured programme of clinical interactions — first procedures, proctoring visits, scientific exchange meetings, congress presence and follow-up. Designed to build clinical credibility at the right pace.
Tender & procurement support
When KOL relationships are sufficiently developed, CCi coordinates the transition from clinical adoption to procurement support — ensuring that clinical advocacy translates into tender specification and purchasing decisions.
Relationship protection & continuity
KOL relationships are fragile when not managed consistently. CCi ensures continuity — regular touchpoints, response to clinical questions, presence at key moments — so that the relationship remains active and productive over time.
Account planning & HQ reporting
Structured account plans for each key account, with regular reporting to HQ on relationship status, clinical activity, competitive intelligence and upcoming opportunities. Full visibility on what's happening and what it means.
Four principles that define how we build and manage KOL relationships.
Clinical first, commercial second
KOL relationships in Italian healthcare are built on clinical respect, not commercial persuasion. CCi approaches every interaction from a clinical standpoint — understanding the surgeon's perspective, the patient outcomes, the procedural context. The commercial conversation follows naturally when the clinical relationship is solid.
Long-term over short-term
A KOL who endorses a product because they genuinely believe in it is worth ten times one who endorses it for transactional reasons. CCi builds for permanence — relationships that survive distributor changes, product updates and market shifts because they are grounded in genuine clinical value and mutual respect.
Quality over quantity
Ten deep relationships with the right KOLs produce more commercial value than one hundred superficial ones. CCi prioritises the clinicians who actually drive adoption decisions in their department and institution — not those who simply have a high profile on a congress programme.
Transparency with HQ
KOL relationship management is often an invisible activity — it happens in corridors and operating theatres, not in spreadsheets. CCi makes it visible through structured reporting: relationship status, clinical activity, competitive intelligence and a clear pipeline from clinical adoption to procurement.
Three phases. From mapping to clinical adoption.
KOL mapping
A structured analysis of the KOL landscape for your device category — identifying the right clinicians, ranking them by strategic priority and designing the engagement approach for each.
- Device category and competitive KOL analysis
- Regional and institutional mapping
- Priority ranking by influence and accessibility
- Engagement strategy per KOL tier
- Existing CCi relationship assessment
Engagement & clinical build
Active management of KOL relationships — introductions, first procedures, clinical exchange, congress presence. Building the clinical credibility that drives adoption.
- Warm introductions where CCi network applies
- First procedure and proctoring coordination
- Scientific and clinical exchange programme
- Congress and event presence management
- Monthly relationship status reporting
Adoption & procurement bridge
When clinical relationships are mature, CCi coordinates the transition from clinical advocacy to procurement support — ensuring that KOL endorsement translates into tender outcomes.
- Clinical champion identification per account
- Tender specification support
- KOL advocacy coordination at procurement stage
- Ongoing relationship maintenance post-award
- Competitive defence of established accounts
A structured KOL network actively supporting clinical adoption and procurement decisions for your device.
From colleagues and clients
"Clodio is both a great General Manager and a great person. He has a strong vision about the High Tech and Life Saving Medical Healthcare field derived from more than twenty years old working experience. He has a strong track record for building the business in new geographies and creating development opportunities."
"Clodio is a very pro active manager who it has been a pleasure to work with over recent years. His approach to job situations has been to listen and then act. This is so important when dealing with companies with differing needs in different countries. Clodio is a great team builder with a special focus on objectives and goals."
Tell us your device category. We'll tell you who the right KOLs are — and whether we already know them.
A 30-minute call is enough to map the KOL landscape for your device and give you a clear picture of where CCi's existing network gives you an immediate advantage.
Schedule a free 30-min call